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Abstract
Background: Under-five mortality remains high in Burkina Faso with significant reductions required to meet
Millennium Development Goal 4. The Acceleration for Maternal, Newborn, and Child Health is being implemented
to reduce child mortality in the North and Center North regions of Burkina Faso.
Methods: The Lives Saved Tool was used to determine the percent reduction in child mortality that can be
achieved given baseline levels of coverage for interventions targeted by the Acceleration. Data were obtained from
the Demographic and Health Survey 2003, the Multiple Indicator Cluster Survey 2006, and the baseline survey for
the program from 2010. In addition to the scale up, scenarios were generated to examine the outcome if secular
trends in intervention coverage change persisted and if intervention coverage levels remained constant.
Results: Scaling up all interventions to their target coverage level showed a potential reduction in under-five
mortality of 22 percent, with district specific reductions in mortality ranging from 14 to 25 percent. The percent
reduction in under-five mortality that might be attributable to the program was 16 percent and varied between 14
and 19 percent by district. Treatment of diarrhea with ORS and malaria with ACTs accounted for the majority of
the reduction in mortality.
Conclusions: These findings suggest that significant reductions in under-five mortality may be achieved through
the scale-up of the Acceleration. The Ministry of Health and its partners in Burkina Faso should continue their
efforts to scale up these proven interventions to achieve and even exceed target levels for coverage.
Background
Burkina Faso remains a country with high under-five
mortality. According to the Demographic and Health
Survey (DHS) of 2003 the under-five mortality rate was
184 deaths per 1,000 live births, with mortality in rural
areas reaching 202 deaths per 1,000 live births [1].
Results from the 2010 DHS confirm that under-five
mortality has been declining [2], but significant reduc-
tions in mortality must be achieved for Burkina Faso to
meet its Millennium Development Goal 4 target of 68
deaths per 1,000 live births [3].
Malaria, pneumonia, and diarrhea are important con-
tributors to child deaths in Burkina Faso and globally,
accounting for 24, 18, and 12 percent of under-five mor-
tality in Burkina Faso and 7, 18, and 11 percent of
under-five mortality globally, respectively [4]. Neonatal
mortality accounts for 22 percent of deaths to children
under five in Burkina Faso and 40 percent globally.
Figure 1 shows the distribution of deaths in Burkina
Faso by cause [4].
In 2008, the Ministry of Health (MoH) began a strat-
egy to accelerate the scale-up of interventions with pro-
ven impact on maternal, neonatal, and child health. The
program, called the Acceleration for Maternal, Neonatal
and Child Health (“Acceleration”), is being implemented
in nine districts in the North and Center North regions.
Malaria treatment with artemisinin combination therapy
(ACT) and diarrhea treatment with oral rehydration
solution (ORS) and zinc are provided at the community
level in all nine districts; treatment of pneumonia with
oral antibiotics is provided in two districts as a pilot. By
the end of 2010, all districts had trained volunteer com-
munity health workers to diagnose and treat malaria
and diarrhea, and, in two districts, suspected pneumo-
nia. In all but one district, where the drug kits were
received in early 2011, community health workers had
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received drug kits. In addition to community case man-
agement (CCM) of childhood illness, the Acceleration
targets the rapid scale-up of several other maternal, neo-
natal and child health interventions. Table 1 presents a
list of all program interventions included in the Accel-
eration and their target coverage levels for 2013.
An ongoing independent evaluation of the Accelera-
tion seeks to assess whether under-five mortality is
reduced by 25% at endline (2013) relative to baseline
(2009) in the program areas, which is the program
objective, and to what extent the reduction in mortality
is attributable to the program. This paper uses the Lives
Figure 1 Causes of under-five mortality in Burkina Faso, 2010
Table 1 Interventions for which coverage is being accelerated, including the indicator definition used in the model
and the intervention target coverage
Coverage intervention Indicator definition used in model 2013
Target
Antenatal Care Proportion of live births in the previous 2 years for which the mother
attended four or more antenatal care visits during the pregnancy
(ANC4+).
80%
Pregnant women protected via intermittent preventive treatment
of malaria (IPT) or sleeping under an insecticide-treated bed net
(ITN)
Proportion of live births in the previous 2 years for which the mother
received 2+ doses of SP/Fansidar during pregnancy.
70%
Proportion of households that own at least one ITN.
Skilled birth attendance (SBA) Proportion of live births in the previous 2 years attended by a skilled
attendant, including doctors, nurses, midwives or auxiliary midwives.
60%
Exclusive breastfeeding for the first six months of life Proportion of children <1 month receiving only breast milk. 20%
Proportion of children 1-5 months receiving only breast milk. 20%
Vitamin A Supplementation Proportion of children 6-59 months of age receiving at least 1 dose of
vitamin A during the last 6 months.
90%
Insecticide treated bed nets or indoor residual spraying Proportion of households owning at least 1 insecticide treated bed net. 70%
Case management of diarrhea (ORS) Proportion of children with suspected diarrhea treated with oral
rehydration solution.
60%
Zinc for treatment of diarrhea Proportion of children 6-59 months of age with suspected diarrhea
treated with zinc
60%
Case management of pneumonia (oral antibiotics) Proportion of children with suspected pneumonia treated with
appropriate antibiotics.
50%
Case management of malaria (ACTs) Proportion of children treated within 24 hours of the onset of fever in
malaria endemic areas with an artemisinin combination therapy.
70%
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Saved Tool (LiST) to model the impact of program
scale-up upon under-five mortality rates using the mea-
sured baseline values and program targets. A previous
analysis of the Acceleration using LiST was instrumental
in establishing the intervention-specific targets for the
program [5].
Methods
Lives Saved Tool (LiST)
LiST is a state-of-the-art modeling software package
that uses available demographic and epidemiologic data
to predict the effect that changes in coverage of health
interventions will have on neonatal, under-five and
maternal mortality [6]. It allows the user to model coun-
terfactual scenarios to calculate not only the impact of a
projected scale up of a health program, but also the
impact relative to any number of alternate scenarios.
LiST draws upon the technical expertise of the Child
Health Epidemiology Reference Group (CHERG) [7] for
estimation of key inputs, such as cause-specific mortality
by country and intervention effectiveness. A description
of the role of CHERG in the development of LiST is
available elsewhere [8]. Supporting documentation for
the interventions included in LiST is referenced within
the software and available in a series of LiST journal
supplements [8,9].
Data sources
LiST requires baseline and end-line coverage levels of an
intervention to project the effect of changes in coverage
on under-five mortality. Intervention coverage measures
the proportion of those needing an intervention who
receive it. Examples of coverage indicators used in this
analysis are shown in Table 1. Baseline coverage values
were obtained from the LiST survey for the independent
evaluation of the Acceleration conducted in 2010 [10].
The survey sampled 1,000 households in each of seven
Acceleration districts and 2,000 households in each of
the remaining two districts, Barsalogho and Gourcy,
where CCM for pneumonia was implemented under the
Acceleration. The survey also sampled 1,000 households
in each of seven comparison districts with comparable
demographic and health systems characteristics for a
total of 18,000 households. The evaluation team
hypothesized that the program would have a heightened
impact in rural areas and therefore only sampled house-
holds from rural areas [10].
Baseline coverage values for LiST interventions came
from the baseline survey report [10]. Where a LiST
intervention was not included in the report, the cover-
age values were calculated by the authors from the sur-
vey database. See Annex Table 1 for a complete list of
intervention coverage values from the baseline survey by
district and region. Some LiST interventions (e.g.,
magnesium sulfate for pre-eclampsia, active manage-
ment of the third stage of labor) are not readily mea-
sured through household surveys. In the absence of
measured coverage data on these interventions, LiST
estimates the coverage based on measured coverage of
ANC4+ or of skilled birth attendance. We used this
approach in our analysis as well.
Data before 2010 were needed to establish trends in
coverage. The 2003 DHS [1] and 2006 Multiple Indica-
tor Cluster Survey (MICS) [11] were used to establish
prior coverage levels. The DHS sample included 9,097
households while the MICS sample included only 5,523
households. Both surveys were conducted nationally.
The relatively larger sample size of the DHS allowed for
the results to be stratified not only by urban or rural
enumeration area but also by region. MICS data were
also stratified by urban and rural area, but regional stra-
tification was not possible. This analysis uses rural cov-
erage values from both surveys to establish a trend
leading up to 2010 for all projections. Regional data
were not used for the reference period because the
national rural coverage estimates from DHS 2003 and
MICS 2006 were more representative of the Accelera-
tion districts than regional estimates that include urban
areas. Also, the lack of regionally-representative data in
the MICS 2006 dataset would have further complicated
the analysis, had regional data from the DHS been used.
Where available, coverage values from MICS were
used preferentially to data from DHS as they were col-
lected more recently. Where an estimated coverage
value for the indicator of interest was only available in
DHS, that value was used instead. An exception to this
rule was made for the percentage of births attended by
a skilled health worker. Both DHS and MICS included
births attended by a trained traditional birth attendant
(Matrone) when calculating this indicator, which is
inconsistent with the current definition that excludes
matrones [12]. The data in the MICS report could not
be disaggregated to exclude matrones, so the indicator
was recalculated from DHS as the sum of births
attended by a doctor, nurse, or midwife.
Analysis
Using data from DHS, MICS and the LiST survey, indi-
vidual projections were created for each program dis-
trict, region, and intervention group. A projection was
also calculated for all 16 districts. Each projection began
with the national DHS and MICS data to establish refer-
ence coverage values for either 2003 or 2006. The data
from 2010 were then entered and interpolated with the
values from 2006 or 2003.
In several instances this approach would have resulted
in a modeled decrease in intervention coverage from the
previous value through 2010. For these cases, we were
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concerned that the higher coverage value in 2003 or
2006 compared with 2010 might not reflect a real
decrease in coverage over time. Instead, the higher value
in 2003 or 2006 might have resulted from the use of
national rural data from these surveys, rather than
region- or district- level rural data. Where this conflict
occurred, the coverage values from the LiST survey
were considered more representative of the population
of interest, and the 2010 values were used in place of
the 2003 or 2006 survey values. Under this approach,
for these interventions and districts we assumed there
was no change in coverage in the projection prior to
2010, resulting in a flat secular trend for these
interventions.
Three scenarios were considered for the period 2010
to 2013 (Figure 2). First, the fixed-coverage scenario
held coverage of all interventions constant at their 2010
level through 2013. Secondly, the scale-up scenario held
coverage of all non-program interventions constant at
their 2010 level and scaled up all program interventions
to meet the MoH targets in 2013. In instances where
the coverage target had been achieved by baseline, we
assumed that coverage continued to increase to 2013,
using the same annual rate of change observed prior to
2010. See Table 2 for baseline and endline coverage
levels for program interventions used in the scale -up
scenario by district. A final projection predicted the
decrease in under-five mortality if the observed changes
in intervention coverage during the reference period
(2003 or 2006 through 2010) continued through 2013.
These trends were calculated by applying the annual
rate of change in coverage of an intervention prior to
2010 to the period 2010-2013. This projection assumed
that once a secular trend caused coverage to reach 90%,
then coverage of that intervention would cease to
increase. Chloroquine for treatment of malaria was
phased out of Burkina Faso beginning in 2005-2006, and
use of ACTs was extremely limited at the time the 2006
MICS was conducted. The average annual rate of
change for antibiotics for pneumonia was therefore used
to project secular trends in treatment with ACTs from
2010 to 2013. All coverage changes were assumed to be
linear.
This analysis created 42 unique projections: one fixed-
coverage, scale-up, and secular trend projection for each
district, region, intervention group, and all districts
together. For each projection, LiST also estimated the
change in under-five mortality from 2010 to 2013, and
the change in mortality attributable to each intervention.
Additional projections were created to examine the
results of scaling up each intervention in isolation and
scaling up all interventions simultaneously.
Results
Table 3 shows the results of the Acceleration scale-up
and secular trend scenarios, including the percent mor-
tality reduction under these scenarios and the difference
in mortality reduction between the two scenarios. The
fixed-coverage scenario predicted minimal reductions in
mortality related to vaccine herd effects in four districts.
In all other districts there was no reduction in mortality
(data not shown).
Scaling up all program interventions to their target
levels by 2013 showed a 14-25% reduction in under-five
mortality in the program districts. The reduction in
mortality under the scale-up scenario exceeded the
reduction in mortality predicted by the secular trend
scenario (Table 2). Districts with lower baseline cover-
age of program interventions, especially the treatment
interventions, were more likely to experience larger
Figure 2 Summary of Fixed-Coverage, Scale Up, and Secular Trend Scenarios
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reductions in mortality under the scale-up scenario, as
shown in Barsalogho and Kongoussi districts (25% and
22% reductions, respectively). Districts where baseline
coverage of the treatment interventions was higher, such
as Titao and Séguénéga, experienced relatively smaller
reductions in mortality.
The difference between the reduction in under-five
mortality as a result of scaling up the program interven-
tions and the reduction in under-five mortality due to
secular trends in coverage change provides an approxi-
mation of the percentage reduction in mortality attribu-
table to the program. There was large variation in
program-attributable mortality reductions in mortality
by district, with the largest reductions in Boulsa, Barsa-
logho, Kongoussi and Titao districts. Scaling up the pro-
gram interventions in these districts accounted for
reductions in under-five mortality that were 14 to 19
percentage points greater than the anticipated reduc-
tions in under-five mortality due to secular trends.
Table 3 shows the results for the intervention-specific
reductions in mortality in all 16 districts if the program
targets are met. The three interventions responsible for
the largest reduction in mortality were case manage-
ment of malaria, diarrhea, and pneumonia. The reduc-
tions in mortality that would be achieved by scaling up
the interventions individually are very similar to the
intervention-specific contributions to reduced mortality
from scaling up all interventions simultaneously.
Each of the scale up projections was also examined to
determine the intervention-specific contributions to the
reduction in mortality. In all district level projections
(results not shown), treatment of diarrhea with ORS and
malaria with ACTs accounted for the majority of the
reduction in mortality. Scaling up coverage of ITNs and
Vitamin A supplementation had a small impact on
Table 2 Percent reduction in under-five mortality from
2010 to 2013 with scale up of interventions, continuation













Center North 23% 6% 16%
Barsalogho 25% 9% 16%
Boulsa 19% 0% 19%
Kaya 20% 15% 6%
Kongoussi 22% 8% 14%
North 19% 6% 14%
Gourcy 20% 7% 13%
Ouahigouya 19% 16% 3%
Séguénéga 14% 11% 3%
Yako 17% 3% 14%




PMNCH with Pneumonia CCM 24% 9% 15%
*Absolute difference may not equal observed difference between columns
due to rounding







Percent Reduction in Under Five
Mortality Due to Intervention
Antimalarials - artemisinin compounds for malaria 26% 70% 44% 10%
ORS - oral rehydration solution 23% 60% 37% 4%
Oral antibiotics : case management of pneumonia in children 33% 60% 27% 3%
Zinc – for treatment of diarrhea 4% 60% 56% 1%
Breastfeeding practices 33% 38% 5% 1%
ITN/IRS - Ownership of insecticide treated nets (ITN/LLIN) or household
protected with indoor residual spraying
64% 70% 6% <1%
Labor and delivery managementa 71% 79% 8% <1%
IPTp - Pregnant women protected via intermittent preventive
treatment of malaria during pregnancy or by sleeping under an ITN
38% 70% 32% <1%
Vitamin A supplementation 89% 90% 1% <1%
Immediate assessment and stimulationa 56% 58% 2% <1%
Clean birth practicesa 60% 64% 4% <1%
Syphilis detection and treatmenta 23% 64% 41% <1%
Total 22%
Note: Coverage of skilled birth attendance and exclusive breastfeeding during the first six months are not listed above because targets for these interventions
had been achieved at baseline.
a Increase in coverage of labor and delivery management, immediate assessment and stimulation, clean birth practices, and syphilis detection and treatment
results from scaling up coverage of mothers receiving at least four antenatal care visits from 45% in 2010 to 80% in 2012.
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mortality in some districts but none in others. Reasons
for these findings are explored in the following section.
Discussion
The results of the scale up scenario predict a reduction
in mortality in each of the program districts, although
the magnitude of the reduction varies greatly between
districts. The Ouahigouya and Séguénéga districts of the
North region show lower reductions in mortality than
the other districts. The reduced program impact in
these districts is consistent with the higher baseline cov-
erage levels of the treatment interventions in these dis-
tricts. Similarly, the lower baseline coverage level of the
treatment interventions in Barsalogho, Boulsa and Yako
districts explains the increased program impact in these
districts.
Case management of malaria with ACTs, diarrhea
with ORS and pneumonia with oral antibiotics were the
program interventions with the most impact wherever
they were implemented. This is due in part to the close
relationship between these interventions and the cause
of death distribution in Burkina Faso, where malaria,
diarrhea, and pneumonia account for 49% of under-five
mortality. Interventions targeting maternal and neonatal
mortality, such as antenatal care and intermittent pre-
ventive treatment of malaria during pregnancy (IPTp),
had less impact on under-five deaths. Neonatal mortality
accounts for a smaller proportion of deaths in Burkina
Faso than globally (22% compared to 40%) [13]. Few of
the interventions targeted neonatal mortality directly,
and the baseline coverage levels of ANC and skilled
attendance at delivery were relatively high. Several other
interventions appeared to have a relatively small effect
on under-five mortality, due to high baseline coverage
of these interventions. Baseline coverage of exclusive
breastfeeding among children younger than six months
and Vitamin A supplementation already exceeded the
program target for coverage in many districts. Although
only one district, Titao, exceed the target coverage for
ITNs of 70%, all other districts had a coverage gap of
20% or less.
A sensitivity analysis examined the potential reduction
in under-five mortality if all interventions were scaled
up to 90% coverage with the exception of Vitamin A
supplementation, for which target coverage was already
90%. This scenario found a much larger reduction in
under-five mortality than if interventions were only
scaled up to their original targets (36% compared to
22%).
Limitations
In the context of the program evaluation, a major lim-
itation of this analysis is that the baseline data were col-
lected in 2010, while program activities began in 2009.
The evaluation team was not invited to make a first visit
to the country until 2009, and was able to conduct the
baseline survey only once funding became available.
CCM of diarrhea, malaria, and pneumonia, which is the
aspect of the program that distinguishes the program
area from other parts of the country, was effective only
at the end of 2010. Program activities such as integrated
management of childhood illness training and vitamin A
campaigns had begun in 2009 prior to the survey; these
activities were also ongoing nationwide. Therefore, this
2010-2013 analysis may not fully capture changes in the
coverage of interventions such as vitamin A supplemen-
tation that are attributable to the program, and may
underestimate the mortality impact.
These findings should be considered within the frame-
work of LiST as a model that relies heavily upon user-
defined assumptions for determining the trajectory of
coverage scale up. The assumptions used were deter-
mined to be the most appropriate for the analysis, but
the limitations of these assumptions should be explored
to understand any potential bias that they might intro-
duce into the results. The method used to determine
the secular trend may be sufficient for drawing a simple
comparison, but could be improved upon. The assump-
tion of linearity for scale up associated with secular
trends in coverage is unlikely to be true. Instead, scale-
up curves are likely to be intervention-specific. For
example, the scale up of long-lasting insecticide treated
bed nets (LLINs) is likely to be a step function. A quan-
tity of LLINs will be distributed in a campaign, as
occurred in Burkina Faso in 2010, resulting in a rapid
increase in coverage, but then coverage will increase
much more slowly until the next LLIN campaign.
Therefore increases in ITN coverage prior to 2010 will
not necessarily continue at the same rate after 2010.
This conflicts with the modeled secular trend for ITN
coverage that showed large increases for most districts
between 2010 and 2013.
These projections are also limited by the available cov-
erage data before 2010. The 2003 Burkina Faso DHS
and 2006 Burkina Faso MICS were representative of
rural areas at national level and were not representative
at district level like the results of the 2010 baseline sur-
vey. Additional data would be required to generate
improved estimates of secular trends at district level,
such as coverage estimates during the period leading up
to 2010. Improved availability of data from this period
would also allow for more accurate modeling of poten-
tial decreases in coverage prior to 2010, which were not
considered in this analysis.
One critique of LiST is that the projected mortality
rates are presented as point estimates with no confi-
dence interval. The demographic and coverage data
used to project population trends are estimated from
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survey data, and intervention effectiveness data are esti-
mated from study results. Country-specific cause of
death structures are also modeled estimates. An uncer-
tainty analysis tool for LiST is in development and will
be included in the software in the future.
Conclusions
This analysis sought to assess the potential mortality
reduction resulting from the Acceleration program in
two regions of Burkina Faso. The results suggest that a
reduction in under-five mortality ranging from 14% to
25% could be achieved by 2013, if program targets are
met. The decrease in mortality over and above the mod-
eled mortality reduction due to secular trends is some-
what smaller. Although these achievements will not
meet the overall Acceleration goal for the nine interven-
tion districts, they represent an important reduction in
child deaths. In order to achieve the greatest reduction
in under-five mortality, the MoH and its partners should
continue their efforts to scale up these proven interven-
tions to target levels of coverage and beyond.
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